Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Moonlake Immunotherapeutics (MLTX)

Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Will this year's top performing stock ETFs stay hot in '24?

Even if there is a clear market rotation, these top performing ETFs will have an opportunity to secure gains and move on to be potential trophy winners in 2024.

ARKK : 54.07 (+2.62%)
FBCG.BZ : N/A (N/A)
VCAR : 16.15 (+18.32%)
COIN : 270.74 (+5.93%)
ROKU : 73.82 (+2.49%)
META : 589.34 (-0.40%)
PLTR : 58.39 (+4.49%)
SHOP : 87.12 (+1.84%)
NVDA : 147.63 (-0.84%)
UBER : 72.04 (-1.49%)
ANF : 143.97 (+1.70%)
DKNG : 40.13 (+2.95%)
Why Shares of MoonLake Immunotherapeutics Are Rising Tuesday

A competitor's clinical trial stumble may be benefiting MoonLake.

SLRN : 5.90 (-0.84%)
MLTX : 51.78 (+2.19%)
MarketBeat Week in Review – 6/26 - 6/30

Markets headed into a holiday week cheering a lower-than-expected key inflation reading, but investors should expect volatility in a short trading week.

NIO : 5.09 (-4.14%)
FROG : 31.10 (-5.36%)
MLTX : 51.78 (+2.19%)
MDB : 290.04 (-1.39%)
SHW : 386.67 (+0.70%)
GIS : 65.52 (+0.89%)
MULN : 1.6500 (-6.25%)
AAPL : 226.96 (-0.23%)
GOOGL : 178.35 (-1.33%)
LCID : 2.21 (-0.45%)
KFY : 78.43 (+0.64%)
META : 589.34 (-0.40%)
Why MoonLake Immunotherapeutics Stock Skyrocketed This Week

Positive mid-stage results fueled a spike in the biotech's shares this week.

MLTX : 51.78 (+2.19%)
MoonLake Immunotherapeutics Makes a Moonshot on Trials

Clinical-stage biotech MoonLake Immunotherapeutics AG (NASDAQ: MLTX) shares spiked 70% on positive clinical trial results.

MLTX : 51.78 (+2.19%)
IMGN : 31.23 (unch)
Why MoonLake Immunotherapeutics Was Such a Healthy Stock Today

The heavily bullish sentiment on the company only grew on the second trading day of the week.

BCS : 13.09 (-1.36%)
MLTX : 51.78 (+2.19%)
Why Shares of MoonLake Immunotherapeutics Skyrocketed Monday

The company reported positive phase 2 clinical trial results.

MLTX : 51.78 (+2.19%)
MoonLake Immunotherapeutics (NASDAQ: MLTX) Announces Breakthrough Results for Sonelokimab in Phase 2 Trial

MoonLake Immunotherapeutics (NASDAQ: MLTX) has made significant strides with the successful outcome of their Phase 2 MIRA trial for sonelokimab,

MLTX : 51.78 (+2.19%)
Lucid Stock Moved Into the Fast Lane, but This Nasdaq Biotech Was Monday's Big Winner

Markets looked poised to start the new week flat.

COMP : 6.70 (-2.90%)
$NASX : 19,286.78 (+0.09%)
LCID : 2.21 (-0.45%)
MLTX : 51.78 (+2.19%)
Stocks Set to Open Lower as Investors Await Key U.S. Inflation Data, Powell Speech

September S&P 500 futures (ESU23) are down -0.12%, and September Nasdaq 100 E-Mini futures (NQU23) are down -0.22% this morning as market participants looked ahead to the release of the Fed’s favorite...

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
TSLA : 321.22 (+8.19%)
NVDA : 147.63 (-0.84%)
JD : 38.35 (-6.99%)
PDD : 117.81 (-6.40%)
KMX : 75.54 (-1.18%)
DBK.D.DX : 15.512 (-3.13%)
AML.LN : 117.600 (-2.00%)
MLTX : 51.78 (+2.19%)
ETNB : 10.45 (+4.92%)
GOOGL : 178.35 (-1.33%)

Barchart Exclusives

3 Best Dividend-growth Stocks Soon To Be Crowned Kings
These three quality companies represent an excellent opportunity for long-term income generation. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar